K063350 - DUAL-CANNULA SYSTEM ACC. MANCAO, SPECIAL SPROTTE (FDA 510(k) Clearance)

K063350 is an FDA 510(k) clearance for the DUAL-CANNULA SYSTEM ACC. MANCAO, SPECIAL SPROTTE. Classified as Needle, Conduction, Anesthetic (w/wo Introducer) (product code BSP), Class II - Special Controls.

Submitted by PAJUNK GmbH Medizintechnologie (Geisingen, DE). The FDA issued a Cleared decision on February 1, 2008 after a review of 452 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5150 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all PAJUNK GmbH Medizintechnologie devices